Schonfeld Strategic Advisors’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ISLE Stock Details ISLE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,701	Closed	-$146K	–	3370
2022 Q2	$146K	Buy	+14,701	New	+$146K	﹤0.01%	2031

Schonfeld Strategic Advisors's ISLE Position: Q3 2022 in Review

Schonfeld Strategic Advisors sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 14,701 shares — an estimated $146K sold.

Schonfeld Strategic Advisors first reported a position in ISLE in Q2 2022 and held it in 1 quarter. The position peaked at $146K in Q2 2022. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

Schonfeld Strategic Advisors reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
Schonfeld Strategic Advisors sold 14,701 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $146K.
Schonfeld Strategic Advisors first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q2 2022 and held it in 1 quarter.
Schonfeld Strategic Advisors's Isleworth Healthcare Acquisition Corporation Common stock position peaked at $146K in Q2 2022.
0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.